DESLORATADINE\PSEUDOEPHEDRINE: 59 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
59
Total FAERS Reports
0
Deaths Reported
18
Hospitalizations
59
As Primary/Secondary Suspect
1
Life-Threatening
Active Ingredient: DESLORATADINE\PSEUDOEPHEDRINE SULFATE ·
First Report: 2008 · Latest Report: 20240601
What Are the Most Common DESLORATADINE\PSEUDOEPHEDRINE Side Effects?
#1 Most Reported
Pruritus
9 reports (15.3%)
#2 Most Reported
Drug ineffective
9 reports (15.3%)
#3 Most Reported
Vasculitis
8 reports (13.6%)
All DESLORATADINE\PSEUDOEPHEDRINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 9 | 15.3% | 0 | 1 |
| Pruritus | 9 | 15.3% | 0 | 1 |
| Insomnia | 8 | 13.6% | 0 | 0 |
| Urticaria | 8 | 13.6% | 0 | 1 |
| Vasculitis | 8 | 13.6% | 0 | 6 |
| Fatigue | 7 | 11.9% | 0 | 1 |
| Hypertension | 7 | 11.9% | 0 | 6 |
| Nephrolithiasis | 7 | 11.9% | 0 | 7 |
| Dyspepsia | 6 | 10.2% | 0 | 0 |
| Product use issue | 6 | 10.2% | 0 | 2 |
| Abdominal discomfort | 5 | 8.5% | 0 | 1 |
| Erythema | 5 | 8.5% | 0 | 0 |
| Exposure during pregnancy | 5 | 8.5% | 0 | 5 |
| Nervousness | 5 | 8.5% | 0 | 0 |
Who Reports DESLORATADINE\PSEUDOEPHEDRINE Side Effects? Age & Gender Data
Gender: 73.2% female, 26.8% male. Average age: 47.9 years. Most reports from: CA. View detailed demographics →
Is DESLORATADINE\PSEUDOEPHEDRINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 0 | 0 |
| 2009 | 1 | 0 | 0 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 0 |
| 2017 | 1 | 0 | 0 |
| 2018 | 2 | 0 | 0 |
| 2019 | 3 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2021 | 2 | 0 | 0 |
| 2022 | 1 | 0 | 0 |
| 2023 | 2 | 0 | 1 |
| 2024 | 3 | 0 | 0 |
What Is DESLORATADINE\PSEUDOEPHEDRINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 24 |
| Urticaria | 5 |
Official FDA Label for DESLORATADINE\PSEUDOEPHEDRINE
Official prescribing information from the FDA-approved drug label.